# SPL026 With or Without SSRIs in Participants With MDD

> **NCT05553691** · PHASE1 · COMPLETED · sponsor: **Small Pharma Ltd** · enrollment: 18 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** SPL026

## Key facts

- **NCT ID:** NCT05553691
- **Lead sponsor:** Small Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-13
- **Primary completion:** 2023-08-03
- **Final completion:** 2023-08-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05553691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05553691, "SPL026 With or Without SSRIs in Participants With MDD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05553691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*